Oxford Cancer Analytics

OXcan has developed a liquid biopsy blood test to detect cancers early, starting with lung cancer, by generating unique blood-based biomarkers through the use of advanced proteomics and AI.

Oxford Cancer Analytics is a business in health based in United Kingdom.

The company sits in the health segment, where it competes on its core product or service.

United Kingdom is where the company is located.

Directory data places it at the Plug and Play accelerated startup stage.

Website: www.oxcan.org